137 related articles for article (PubMed ID: 38117306)
21. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].
Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398
[TBL] [Abstract][Full Text] [Related]
22. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
[TBL] [Abstract][Full Text] [Related]
23. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
24. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
25. Warthin-like variant of papillary thyroid carcinoma with lymph node metastases: a case report and review of the literature.
Hryshchyshyn A; Bahrii A; Botsun P; Chuba V
J Med Case Rep; 2024 Jan; 18(1):17. PubMed ID: 38221623
[TBL] [Abstract][Full Text] [Related]
26. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
[TBL] [Abstract][Full Text] [Related]
27. [Predictors of level V lymphatic metastasis in papillary thyroid carcinoma].
Chen R; Wei T; Li ZH; Gong RX; Zhu JQ
Zhonghua Wai Ke Za Zhi; 2012 Jul; 50(7):625-8. PubMed ID: 22943994
[TBL] [Abstract][Full Text] [Related]
28. [Clinical features of postoperative cervical lymph nodes recurrence in papillary thyroid carcinoma].
He YY; Zhang B; Zhang YB; Xu ZG; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):416-420. PubMed ID: 28635212
[No Abstract] [Full Text] [Related]
29. Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients.
Lu Y; Jiang L; Chen C; Chen H; Yao Q
Medicine (Baltimore); 2020 Apr; 99(15):e19795. PubMed ID: 32282744
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis.
Zhao J; Zhang Y; Zheng X
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):635-638. PubMed ID: 35210104
[TBL] [Abstract][Full Text] [Related]
31. Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.
Liu WQ; Yang JY; Wang XH; Cai W; Li F
BMC Surg; 2022 Jun; 22(1):228. PubMed ID: 35701785
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].
Huang H; Xu Z; Wang X; Wu Y; Liu S
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598
[TBL] [Abstract][Full Text] [Related]
33. Thyroglobulin Measurement in Fine-Needle Aspiration Improves the Diagnosis of Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma.
Al-Hilli Z; Strajina V; McKenzie TJ; Thompson GB; Farley DR; Regina Castro M; Algeciras-Schimnich A; Richards ML
Ann Surg Oncol; 2017 Mar; 24(3):739-744. PubMed ID: 27738849
[TBL] [Abstract][Full Text] [Related]
34. Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer.
Lindfors H; Karlsen M; Karlton E; Zedenius J; Larsson C; Ihre Lundgren C; Juhlin CC; Shabo I
Sci Rep; 2023 Jan; 13(1):1070. PubMed ID: 36658256
[TBL] [Abstract][Full Text] [Related]
35. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
37. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
[TBL] [Abstract][Full Text] [Related]
38. Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial.
Cabrera RN; Chone CT; Zantut-Wittmann D; Matos P; Ferreira DM; Pereira PSG; Ferrari RJR; Santos AO; Crespo AN; Etchebehere ECSC
Eur Arch Otorhinolaryngol; 2015 Apr; 272(4):971-979. PubMed ID: 24695942
[TBL] [Abstract][Full Text] [Related]
39. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
Gao X; Luo W; He L; Cheng J; Yang L
Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
